| AIF | Apoptosis-inducing factor |
| ATG | Arctigenin |
| BAX | Bcl-2-associated X protein |
| Bcl-2 | B-cell lymphoma 2 |
| Bcl-xL | B-cell lymphoma-extra large |
| BCRP | Breast cancer resistance protein |
| CI-Fa | Combination index-Fraction affected |
| COX IV | Cytochrome c oxidase subunit 4 isoform 1 |
| Dox | Doxorubicin |
| ERK | Extracellular signal-regulated kinase 1/2 |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase |
| H2A.X | H2A histone family member X |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hormone receptor |
| JNK | C-Jun N-terminal kinase |
| LC3 | Microtubule-associated protein 1A/1B-light chain 3 |
| MRP1 | Multidrug resistance-associated protein 1 |
| mTOR | Mammalian target of rapamycin |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NSCLC | Non-small cell lung cancer |
| PARP | Poly (ADP-ribose) polymerase |
| RIPK3 | Receptor-interacting serine/threonine-protein kinase 3 |
| ROS | Reactive oxygen species |
| S6 | Ribosomal protein 6 |
| STAT3 | Signal transducer and activator of transcription 3 |
| TNBC | Triple-negative breast cancer |